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Abstract 
Background: Medicinal plant research may contribute to develop new pharmacological control tools for vector 
borne diseases, such as malaria.
Methods: The effects of methanol extracts (ME) obtained from seed kernel of ripe and unripe Azadirachta indica 
fruits were studied on erythrocytic proliferation of the rodent malaria parasite Plasmodium berghei strain ANKA and 
on mice pro‑inflammatory response, as evaluated by measuring the matrix‑metalloproteinase‑9 (MMP‑9) and tumour 
necrosis factor (TNF) plasma levels, in two mouse strains (C57BL/6 and BALB/c) which are considered as prototypical 
of Th1 and Th2 immune response, respectively.
Results: ME obtained from seed kernel of unripe Azadirachta indica fruits decreased by about 30% the proportion 
of erythrocytes infected with the malaria parasite in C57BL/6 mice in the 4 days suppressive test. In this treatment 
group, MMP‑9 and TNF levels were notably higher than those measured in the same mouse strain treated with the 
anti‑malarial drug artesunate, Azadirachta indica kernel extracts from ripe fruits or solvent. In BALB/c mice, treatment 
with kernel extracts did not influence parasitaemia. MMP‑9 and TNF levels measured in this mouse strain were notably 
lower than those recorded in C57BL/6 mice and did not vary among treatment groups.
Conclusions: The effects of the ME on the parasite‑host interactions appeared to be mouse strain‑dependent, but 
also related to the ripening stage of the neem fruits, as only the unripe fruit seed kernel extracts displayed appreciable 
bioactivity.
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Background
Although the malaria burden has decreased worldwide 
over the last 15  years, this mosquito-borne parasitic 
disease continues to cause high morbidity and mortal-
ity, particularly in children in Africa south of Sahara [1]. 
According to World Health Organization (WHO) esti-
mates, in 2016 there were about 195 million cases and 
406,000 deaths in the African Region. Eighty percent of 
these cases and deaths occurred in 15 sub-Saharan coun-
tries and one-third in only two, namely Nigeria and the 
Democratic Republic of the Congo [1].
Significant achievements in rolling back malaria have 
been obtained in areas of relatively low malaria transmis-
sion within countries which are socio-economically bet-
ter off and/or capable to achieve a high coverage of the 
recommended key control tools, as insecticide-treated 
bed nets and artemisinin-based combination therapy 
(ACT). However, even countries which have been rela-
tively successful may not be able to maintain their 
achievements in the fight against malaria. In fact, diffu-
sion of insecticide resistance has reached alarming levels. 
In 2015, over three quarters of the 73 malaria endemic 
countries monitoring pyrethroid efficacy have reported 
resistance to this class of insecticides, used to treat the 
bed nets [2]. Furthermore, malaria control attainments 
are threatened by the emergence and diffusion of arte-
misinin resistance, to date confirmed in five countries of 
the Greater Mekong sub-region in Asia [3].
In this scenario, medicinal plant research may con-
tribute to develop new pharmacological control tools 
pursuing the following objectives: (1) to identify new 
anti-malarial drug leads of plant origin, active against 
the asexual blood stages of Plasmodium, responsible for 
the disease, and/or against the stages responsible for its 
transmission, i.e. the gametocytes in the vertebrate host 
and the sporogonic stages in the mosquito; (2) to develop 
standardized, effective and safe anti-malarial phytomedi-
cines (curative and transmission-blocking), based on 
a detailed chemical and biological characterization of 
plants.
Azadirachta indica (Meliaceae), well known as neem 
tree and renowned as a medicinal plant able to cure a 
wide range of ailments, makes part of the pharmacopeia 
of various traditional medicine systems worldwide and is 
used in different African countries for the prevention and 
treatment of malaria [4]. For the management of malaria 
fevers, homemade neem infusions from leaves and 
bark—also in combination with other plants—are fre-
quently employed. Nowadays, several standardized, com-
mercial preparations are available, as, e.g. neem tea bags 
(NEEM & MUARUBAINI 25S TEA BAGS) in Kenya and 
capsules containing fractionated leaf extract (IRACARP) 
in Nigeria [5].
The perceived efficacy of Azadirachta indica for the 
management of malaria fevers may in part be due to its 
antipyretic properties, reported for leaves, stem bark, 
roots and fruits [6]. From a wide spectrum of experi-
ments, conducted on various plant parts in  vitro and 
in vivo, it emerges that the plant most likely harbours a 
variety of molecules able to interfere with the pathophys-
iology of fever, with the inflammatory response and with 
the regulation of humoral and cell-mediated immunity 
[4].
Chemical and biological characterization studies 
allowed more than 300 neem compounds from vari-
ous plant parts to be identified [7], including at least 50 
limonoids [8]. Among these, in vitro anti-malarial effects 
have been evidenced for gedunin [9], nimbin [10], nim-
bolide [10], azadirone and neemfruitin A [11]. The latter 
two, isolated from Azadirachta indica fruits, inhibit Plas-
modium falciparum (W2 chloroquine-resistant strain) 
schizogonic replication by 50% at a concentration lower 
than 2  μM [11]. Azadirachtin—not active against blood 
stages—was found to interfere with early sporogonic 
development in the mosquito vector [12, 13], inhibiting 
50% of ookinete formation in vitro at about 17 µM [14].
Most studies exploring the in vivo anti-malarial activ-
ity of Azadirachta indica employed the 4-day suppres-
sive test, which assesses impact on asexual blood stages 
multiplication (parasitaemia) in an infect-and-treat 
scheme. Results from leaves and bark extracts adminis-
tered at relatively high dosages (0.2 to 1 g/kg) have been 
overall moderate, ranging from 0 to 80% suppression of 
parasitaemia in mice infected with Plasmodium berghei 
or Plasmodium yoelii (reviewed by Willcox and Bodeker 
[4]). Preventive potential emerged from a ripe fruit eth-
anol extract that reduced parasitaemia by about 45% in 
mice treated for 9 days at 200 mg/kg/day [15].
Taking into account the various anti-malarial effects 
demonstrated by Azadirachta indica fruit preparations 
and considering literature evidence on the immune-mod-
ulatory properties of the plant [4, 7], this study aims at 
exploring the effects of Azadirachta indica fruits (seed 
kernel part) on the parasite-host association, consider-
ing the characteristics of the treated hosts’ reactions to 
parasitaemia. Accordingly, we measured matrix-metallo-
proteinase-9 (MMP-9) and tumour necrosis factor (TNF) 
levels as indicators of pro-inflammatory response activa-
tion in BALB/c and C57BL/6 mice, two strains exhibiting 
different immune competency characteristics [16].
Methods
Plant material
The Azadirachta indica ripe and green fruits were col-
lected near Farakoba, in Burkina Faso in May 2014 by R. 
S. Y. and Dr. Pascal Dipama of the Institut de Recherche 
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en Sciences de la Santé (IRSS), Bobo Dioulasso. The 
plant was identified by Dr. Paulette Tahita (Institut de 
l’Environnement et de Recherches Agricole, Centre de 
la Protection des Végétaux) and deposited at the Unit of 
Parcelle expérimentale de l’IRSS Bobo Dioulasso, voucher 
number Azadirachta indica RF052014 and Azadirachta 
indica GF052014 for Azadirachta indica ripe and green 
fruits, respectively.
Preparation of methanol extracts (ME) from ripe 
and unripe neem fruit kernels and their chemical 
characterization
Epicarp and mesocarp parts were removed from both 
ripe and unripe Azadirachta indica fruits and peeled 
seeds grounded to obtain fine powders of the ripe and 
unripe fruit kernel. Fruit kernel powders were extracted 
with methanol (100  ml × 3 times) at room temperature 
for 24 h and then concentrated under vacuum to obtain 
the extracts for the biological experiments.
For chemical characterization, ripe fruit kernel powder 
(135  g) was repeatedly extracted with MeOH (1.5  l × 3 
times) at room temperature for 24  h and then concen-
trated under vacuum to obtain a crude methanol extract 
(26  g). The obtained material was then partitioned 
between  H2O and Ethyl Acetate (EtOAc) to yield an 
organic extract (12 g). This was subjected to chromatog-
raphy over silica column (230–400 mesh) eluted with a 
solvent gradient of increasing polarity from n-hexane to 
EtOAc. Fractions eluted with n-hexane/EtOAc 9:1 pro-
vided azadirone (120 mg) in pure state. Fractions eluted 
with n-hexane/EtOAc 8:2 contained epoxyazadiradione 
and azadiradione (ca. 100  mg). Fractions eluted with 
n-hexane/EtOAc 7:3 contained nimbin (100  mg). Frac-
tions eluted with n-hexane/EtOAc 6:4 provided deacetyl-
nimbin (420 mg). Fractions eluted with n-hexane/EtOAc 
1:1 contained pure salannin (376  mg). Finally, fractions 
eluted with increasing polarity from n-hexane/EtOAc 5:5 
to 2:8 gave a mixture of azadirachtin A and analogues (ca. 
1 g). The same procedure was repeated with the powder 
(130 g) of unripe fruit kernel to obtain a crude methanol 
extract of 24 g. Separation of the EtOAc phase (12.6 g) of 
unripe fruit provided the same metabolites and the same 
amounts compared to ripe fruit with the following excep-
tions: (a) nimbin was practically undetectable in unripe 
fruit; (b) deacetylnimbin was consistently less abundant 
in unripe fruit (300 mg); (c) salannin was more abundant 
in unripe fruit (451 mg) than in ripe fruit. Chromatogram 
of methanol extract from neem fruit kernel is shown in 
Additional file 1.
Animals
Two inbred mouse strains with different immune 
response characteristics, namely BALB/c and C57BL/6, 
were chosen for this study. On the basis of differences in 
their respective Major Histocompatibility Complex [17], 
the former is a prototypical Th2 response strain, while 
the latter is prone to develop a Th1 type of response [16].
The BALB/c mice were reared and maintained 
under standard conditions at 24  °C of temperature, 
14 h light/10 h dark cycle and 70% humidity in the ani-
mal facility of the University of Camerino (Italy). The 
C57BL/6 mice were purchased from ENVIGO Laborato-
ries, Inc., (Udine, Italy) and maintained under the same 
standard conditions as described above.
This study was carried out in accordance with the rec-
ommendations of the Italian Legislative Decree on the 
“Use and protection of laboratory animals” (D. Lgs. 116 of 
10/27/92) and in full adherence with the European Direc-
tive 2010/63/UE, adopted on 22nd September, 2010. The 
protocol was approved by the University Research Ethics 
Committee of the University of Camerino—protection of 
animals used for experimental and other scientific pur-
poses (protocol number: UREC_CAM_2015/18).
Parasite strain
The chloroquine sensitive Plasmodium berghei strain 
ANKA was used to assess the in vivo effects of the neem 
extracts. The ANKA strain, specific for rodent hosts, is 
widely employed in anti-malarial drug discovery studies 
[18] and is lethal for both, BALB/c and C57BL/6 mice. 
This parasite strain is routinely maintained in the labo-
ratory of parasitology at the University of Camerino by 
mouse to mouse (acyclic) and mouse to Anopheles ste-
phensi mosquito (cyclic) passages. Blood aliquots from 
mice infected after cyclic passage are stored at − 120 °C 
in liquid nitrogen using haematocrit capillaries.
Assessment of parasitaemia progression in BALB/c 
and C57BL/6 mice
The development of parasitaemia was comparatively 
assessed in BALB/c and C57BL/6 mice. Five to six mice 
per strain were i.p. infected with  107 P. berghei-infected 
red blood cells (iRBCs) and parasitaemia was measured 
daily on Giemsa-stained blood smears, starting from day 
3 until mice began to show general signs of illness such 
as ruffled fur, squinted eyes, hunched position and reluc-
tance to move. These signs started appearing on day 12 
for BALB/c and on day 9 for C57BL6 mice. Thin blood 
smears were prepared using a drop of blood from the 
tail tip. After fixation of the smears with methanol, slides 
were stained with 10% Giemsa diluted in PBS (pH 7.3) 
for 60 min. Percent parasitaemia was determined by enu-
merating infected and un-infected RBCs over three opti-
cal fields (1000× magnification) with at least 200 RBCs 
per field.
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Four‑day suppressive test
To assess the in vivo activity of kernel methanol extracts 
(ME) on parasitaemia of P. berghei in BALB/c and 
C57BL/6 mice, the 4-day suppressive test was employed 
[19]. Briefly, healthy female donor mice (3 BALB/c and 
3 C57BL/6) were inoculated intraperitoneally (i.p.) with 
parasitized blood from freshly thawed haematocrit cap-
illaries. Mice parasitaemias were assessed at day 5 to 6 
post-infection and animals with parasitaemia ranging 
between 2 and 5% were selected as blood donors for the 
infection of experimental mice. At day zero, 28 female 
BALB/c and 28 female C57BL/6 mice (6 week old) were 
i.p. injected with  107 iRBCs each from donor mice, 
diluted in 200  μl of PBS. After infection, mice of each 
strain were randomly divided into 4 groups of six animals 
and treated orally as follows: group (a) control, treated 
with solvent  (H2O containing 10% DMSO and 5% Tween 
80); group (b) artesunate 10  mg/kg; group (c) ripe fruit 
kernel ME 150  mg/kg and group (d) unripe fruit kernel 
ME 150  mg/kg. A total of 4 treatments were effected 
from day 0 to day 3 by oral gavage (200 µl/mouse/treat-
ment). The first treatment was given 2 h post infection. 
Parasitaemia of individual mice was evaluated at day 4 
post infection by microscopic examination of Giemsa-
stained blood smears as described above.
Plasma level determination of matrix‑metalloproteinase‑9 
(MMP‑9) and tumor necrosis factor
At the end of the 4 days suppressive test, blood was col-
lected from each experimental mouse by heart puncture, 
using heparinized (1000  IU/ml) 1  ml insulin syringes, 
and their plasma isolated by centrifugation at 3000 rpm 
for 10 min. Plasma levels of MMP-9 were measured by a 
sandwich ELISA commercial kit (Raybiotech, Norcross—
Georgia, USA), which employs a biotinylated mono-
clonal antibody specific for both the pro- and the active 
forms of MMP-9, with a threshold sensitivity of 50 pg/ml. 
Plasma levels of TNF were assessed by a similar sandwich 
ELISA kit (eBioscience Inc., San Diego, California, USA), 
based on a biotinylated monoclonal antibody specific for 
the mouse TNF cytokine, with a threshold sensitivity of 
8 pg/ml. Plates were read with a  Victor3® Multilabel Plate 
Reader (Perkin-Elmer) at 450 nm.
Statistical analysis
Parasitaemia values of treated and control mice were 
compared employing GraphPad PRISM 5 software 
and using the parametric unpaired t test. The enzymes’ 
plasma levels were compared by a two-ways ANOVA, 
using as post-test the Bonferroni analysis and by Dun-
nett’s Multiple Comparison Test. Significant differences 
were considered when p < 0.05.
Results
Comparative assessment of Plasmodium berghei 
parasitaemia in BALB/c and C57BL/6 mice
Examination of Giemsa-stained blood smears, taken 
from day 3 after infection to day 9 (C57BL/6 mice) and 
to day 12 (BALB/c mice), revealed that initial parasi-
taemia development (day 3 to 5) was similar in both 
strains (Fig.  1). On day 4 after infection the percentage 
of infected red blood cells amounted to 9.9% (SD ± 5.5%) 
in BALB/c mice and to 13.1% (SD ± 4.2%) in C57BL/6 
mice. From day 6 to 9 after infection, BALB/c mice 
showed individual up and down fluctuations of parasi-
taemia, remaining until day 9 at a moderate level (19.2%; 
SD ± 9.0%). In C57BL/6 mice, at day 9, a mean of 58.3% 
(SD ± 15.0%) of red blood cells were found to be infected, 
demonstrating the parasite’s ability to strongly proliferate 
in this mouse strain within less than 10 days of infection. 
On day 9, C57BL/6 mice started also to show general 
signs of illness such as ruffled fur, squinted eyes, hunched 











































Fig. 1 Course of Plasmodium berghei strain ANKA parasitaemia in a BALB/c and b C57BL/6 mice. Plots of individual mouse parasitaemia (%). Mice 
were suppressed at the onset of clinical signs, i.e. C57BL/6 mice on day 9 and BALB/c mice on day 12
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position and reluctance to move and had to be sacrificed 
for ethical reasons. The capacity of BALB/c mice to con-
trol parasitaemia notably decreased between day 10 and 
day 12 in some individuals. On day 12, individual para-
sitaemia values ranged between 7.4 and 59.0% (mean 
29.7%; SD ± 19.0%) and mice starting to show signs of ill-
ness had to be suppressed.
In vivo activity of methanol extracts (ME) of Azadirachta 
indica ripe fruit kernel and unripe fruit kernel on P. berghei 
parasitaemia
According to the 4-day suppressive test protocol, the 
impact of ME from ripe and unripe fruit kernel of neem 
on parasitaemia in C57BL/6 and BALB/c mice was deter-
mined on day 4 after infection and after 4 days of treat-
ment. Artesunate, chosen as reference for an effective 
control of parasitaemia, administered at the estimated 
 IC50 dose of 5  mg/kg, reduced parasitaemia by 45% in 
C57BL/6 mice and by 60% in BALB/c, as compared to the 
respective untreated (i.e., solvent-administered) controls 
(data not shown). C57BL/6 and BALB/c mice, treated 
with kernel extract of unripe fruits, showed a parasi-
taemia of 5.4% (SD ± 1.3%) and 7.4% (SD ± 3.1), respec-
tively, quite similar to that of mice treated with kernel 
extracts from ripe fruits, showing a parasitaemia of 5.1% 
(SD ± 3.6) and 7.4% (SD ± 7.7) in C57BL/6 and BALB/c 
mice, respectively. In C57BL/6 mice, parasitaemia at day 
4 appeared to be reduced by about 30% in groups treated 
with the neem preparations compared to the solvent-
administered controls. In particular, the 27% parasi-
taemia reduction obtained with the unripe fruit kernel 
extract resulted statistically significant (p = 0.024). As it 
comes clear from Fig. 2a, a very high inter-individual var-
iation of parasitaemia values was observed in C57BL/6 
mice treated with the ripe fruit kernel extract. In BALB/c 
mice, no impact on parasitaemia was observed with 
none of the neem preparations (Fig. 2b). As in the case of 
C57BL/6 mice, a remarkable inter-individual variability 
was observed in BALB/c mice treated with the ripe fruit 
kernel extract.
Plasma levels of matrix‑metalloproneinase‑9 (MMP‑9) 
and TNF in BALB/c and C57BL/6 mice infected with P. 
berghei and treated with ripe fruit and unripe fruit kernel 
extracts of Azadirachta indica
Considering the indication of some reduction of P. 
berghei parasitaemia with the extract of unripe fruit ker-
nel in C57BL/6 but not in BALB/c mice, the question was 
explored whether parasitaemia reduction in the former 
could be associated to an immune-modulatory effect of 
Azadirachta indica constituents. To investigate on this 
issue, plasma levels of MMP-9 and TNF, as indicators of 
pro-inflammatory response activation, were assessed in 
blood collected from the C57BL/6 and BALB/c mice at 
the end of the observation period, i.e. at day 4 after infec-
tion and treatment.
In all the four groups (artesunate, solvent, unripe and 
ripe fruit kernel extracts) the TNF plasma levels were 
significantly (p = 0.001) lower in BALB/c with respect 
to C57BL/6 mice (Fig. 3a). As to the effects of the treat-
ments within each mouse strain, the 4 treatments were 
Fig. 2 Percentage of parasitaemia of Plasmodium berghei strain ANKA in BALB/c and C57BL/6 mice at day 4 of infection, after 4 days of treatment 
with: artesunate (5 mg/kg), solvent  (H20 containing 10% DMSO, 5% Tween 80), unripe (150 mg/kg) and ripe (150 mg/kg) fruit kernel extracts. a 
Individual parasitaemia values for BALB/c mice, according to treatment group. 1)Data point outside axis limit. b Individual parasitaemia values for 
C57BL/6 mice, according to treatment group. In a, b means and SD values are depicted as horizontal and vertical bars respectively. The horizontal 
square bracket in b indicates significant difference (p = 0.024) between solvent control and unripe fruit kernel treatment. The artesunate treated 
group consistently showed parasitaemia levels lower than those of the other groups
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not associated with any significant difference among the 
BALB/c mice groups infected with P. berghei.
In C57BL/6 mice, the TNF plasma levels were similar 
in the solvent- (95.2 pg/ml; SD ± 42.7), in the artesunate- 
(81.5 pg/ml; SD ± 51.1) and in the ripe fruit kernel extract 
treated group (90.6  pg/ml; SD ± 67.9). In the group of 
mice treated with unripe fruits, a mean TNF level of 
132.3 pg/ml (SD ± 78.0) was measured, which was about 
50% higher than those recorded in the other 3 groups. 
The difference, however, did not achieve statistical sig-
nificance (p = 0.215). Remarkably, the values recorded 
in the infected groups were consistently much higher 
than those of uninfected mice (20.9  pg/ml; SD ± 7.3), 
determined on a group of age and sex matched mice, not 
included in the experiment (p = 0.001).
As far as MMP-9 is concerned, in mice treated with 
kernel extract from unripe fruit the enzyme levels dif-
fered by a factor of about 4 between the 2 mouse strains, 
with the C57BL/6 mice showing a level of 30.9  ng/ml 
(SD ± 18.5) versus the 7.1  ng/ml (SD ± 3.3) observed in 
BALB/c mice (p = 0.047, t test plus Welch’s correction) 
(Fig. 3b). In the ripe fruit- (C57BL/6: 12.4 ng/ml, SD ± 8.2; 
BALB/c: 9.4  ng/ml, SD ± 6.5) and in the solvent-treated 
mice (C57BL/6: 15.9 ng/ml, SD ± 9.7; BALB/c: 8.6 ng/ml, 
SD ± 8.5) only slightly higher values were observed in the 
C57BL/6 than in the BALB/c mice.
As to the within strain treatment effects, no differences 
could be observed in BALB/c mice. On the other hand, 
in C57BL/6 mice, about 5 times higher MMP-9 levels 
were observed in the unripe fruit treated group (30.9 ng/
ml; SD ± 18.5) compared to the artesunate-treated mice 
(5.73  ng/ml; SD ± 5.7; p = 0.024). Two to three times 
higher values were measured in the unripe fruit kernel 
treated group with respect to the solvent and ripe fruit 
kernel group. This difference, however, was not statisti-
cally significant due to considerable within-group vari-
ability (p = 0.075). A significant difference (p = 0.047) in 
unripe fruit treatment between BALB/c and C57BL/6 
mice (p = 0.047) was observed.
Discussion
With the aim of exploring the biological effects of neem 
preparations on parasite-host interactions, two geneti-
cally different mouse strains, i.e. C57BL/6 and BALB/c, 
known to be prone to develop a Th1 response and a Th2-
biased adaptive immune response, respectively, were 
employed. The mouse malaria parasite P. berghei causes 
lethal infections in both strains, but C57BL/6 mice tend 
to die of cerebral malaria while BALB/c mice prevailingly 
show severe anaemia and prostration [20].
Comparing the course of P. berghei blood stage infec-
tion in the two mouse strains, similar levels of parasitae-
mia were observed in the initial phase of infection. On 
day 4 after i.p. inoculation of infected red blood cells, 
parasitaemia measured in BALB/c and C57BL/6 mice 
amounted 9.9% and 13.1% (preliminary, comparative 
experiment) and 6.5% and 7.5% (control groups of the 
neem study). However, from day 6 to 9, C57BL/6 mice 
showed a rapid increase in parasitaemia and signs of 
clinical illness, whereas BALB/c mice displayed a slower 
parasite proliferation and signs of disease only by day 
12. Very similar patterns of parasite proliferation have 
been observed in the two mouse strains in other studies 
conducted with P. berghei [21, 22] and with Plasmodium 
yoelii [23]. Exploring cytokine response in the course 
























































Fig. 3 a TNF and b MMP‑9 plasma levels of P. berghei‑infected C57BL/6 and BALB/c mice after 4 days of treatment with unripe and ripe fruit extracts 
(150 mg/kg), artesunate (5 mg/kg) and solvent solution. Values are expressed as pg/ml and ng/ml, respectively. The horizontal square bracket in b 
indicates significant difference (p = 0.024) between artesunate and unripe fruit treatment in C57BL/6 mice and in unripe fruit treatment between 
the two strains of mice (p = 0.047)
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proliferation in BALB/c mice during the second week of 
infection has been associated to markedly higher levels 
of the Th2 cytokines, namely IL4 from day 5 of infection 
and IL10 from day 7 onwards, indicating the onset of a 
Th2-orchestrated humoral response in this mouse strain 
[22].
In this study, TNF levels, measured on day 4 after infec-
tion, resulted notably lower in BALB/c than in C57BL/6 
mice, irrespective of the treatment group. This indicates 
different, specific patterns of innate immune response 
to infection with P. berghei in the two mouse strains. A 
strain-specific early immune response has been observed 
also with Chlamidia muridarum, a bacterial agent caus-
ing pulmonary infections in mice [24]: 2 days after nasal 
infection, recruitment of macrophages and myeloid den-
dritic cells in the lung was found to be significantly higher 
in C57BL/6 than in BALB/c mice. When cytokine pro-
duction by peritoneal macrophages was explored in these 
two mouse strains, notably higher TNF production was 
observed in lipopolysaccharide or MALP-2 (synthetic 
lipopeptide) stimulated macrophages from C57BL/6 
mice than in those from BALB/c [16].
After i.p. inoculation of infected blood in healthy 
mice, elimination of Plasmodium infected erythrocytes 
occurs mainly in the spleen by cells of the monocyte-
macrophage lineage [25]. Studies conducted with P. yoe-
lii in various mouse strains showed that IFN-γ and TNF 
are essential for macrophage activation and early control 
of parasitaemia, as these cytokines are produced already 
24  h after infection by γδ T lymphocytes and natural 
killer cells [26].
In vivo findings of higher plasma levels of TNF in P. 
berghei-infected C57BL/6 as compared to uninfected 
mice are fully in line with the above-quoted results.
Besides confirming the findings of TNF levels generally 
higher in C57BL/6 mice than in BALB/c mice, our exper-
iments showed that C57BL/6 mice treated with methanol 
extract from seed kernel of Azadirachta indica unripe 
fruits had higher TNF and markedly higher MMP-9 
levels than the other treatment groups. Interestingly, in 
this treatment group a slight decrease of parasitaemia 
was observed 4  days after infection and after 4  days of 
treatment. On the basis of the summarized knowledge 
on early unspecific immune response, this result may 
indicate an adjuvant-like effect of the plant preparation, 
enhancing initial pro-inflammatory response and/or 
macrophage activation.
Both extracts obtained from seed kernels of ripe and 
unripe fruits are a very complex mixture of second-
ary metabolites, dominated by limonoids, a class of 
highly oxidized tetranotriterpenes, usually character-
ized by complex polycyclic structures. The preliminary 
investigation of the limonoid content of Azadirachta 
indica seed kernel revealed some significant differences 
according to their stage of maturation. This is not sur-
prising, having been already observed for limonoids of 
other plants [27]. More specifically, in our study the 
extract from unripe fruits showed a higher amount 
of salannin and a much lower amount of nimbin/dea-
cetylnimbin than that detected in the ripe fruit. It can 
be hypothesized that these differences are responsible 
for the observed differential effect on parasitaemia and 
pro-inflammatory response in C57BL/mice, although 
the contribution of complex synergic effects cannot be 
evaluated at this stage.
The fact that Azadirachta indica extracts increase 
the levels of MMP-9 as well as of TNF are apparently 
contradictory with the observed antipyretic effects 
of leaves, stem bark, roots and fruits from this plant. 
Information on traditional use of neem (leaves, stem 
bark roots and fruits) as an antipyretic stems from the 
ethnobotanical studies conducted in India [6]. Re-look-
ing at the original paper, it is difficult to sort out the 
question since it is not specified whether ripe or unripe 
fruits are used. On the basis of these results it is plausi-
ble that traditionally ripe fruits are employed.
Immuno-modulatory properties have been reported 
for various parts of Azadirachta indica, such as leaves, 
fruits and barks. For example, neem seed oil (also rich 
in limonoids) injected i.p. in BALB/c mice was found 
to increase peritoneal leukocyte counts, enhance the 
phagocytic activity of macrophages and induce the pro-
duction of IFN-γ by spleen cells [28]. Weekly adminis-
tration of a neem leaf preparation for 1 month to Swiss 
albino mice was found to increase total red blood cell, 
white blood cell and platelet counts at all experimental 
doses. In addition, an increase of spleen T lymphocytes 
(CD4+ and CD8+) and NK cells was observed in neem 
treated mice [29].
Immuno-modulatory effects have been also reported 
for other plants and have been associated to com-
pounds biogenetically different from limonoids. For 
example, anti-inflammatory effects have been reported 
for Punica granatum, a plant traditionally used in India 
to treat malaria. A tannin rich fraction of the fruit and 
the isolated constituents ellagic acid and punicalagin 
inhibited MMP-9 expression and secretion in human 
THP-1 monocytic leukaemia cells, fed with haemozoin 
or TNF [30].  Since the same fraction and constituents 
inhibited the in  vitro growth of P. falciparum asexual 
blood stages [31], the authors suggested that Punica 
granatum treatments may be beneficial to manage 
uncomplicated malaria disease and limit the risk of 
onset of cerebral malaria by controlling the excessive 
inflammatory response of the host [30].
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Exploring the potential of Azadirachta indica for the 
management of leishmaniasis, both, anti-protozoan 
and immune-modulatory effects have been detected 
on infected mononuclear cells treated with an ethyl-
acetate fraction of neem leaves [32] and with ethanol 
extracts from neem leaves and seeds [33]. This latter 
extract exerted anti-amastigote activity in RAW 264.7 
cells (macrophage-like cell line), while both extracts 
reduced organ parasite burden in the liver and spleen 
by more than 80%. Spleen cells from infected BALB/c 
mice treated with the two extracts were found to pro-
duce higher levels of Th1 cytokines TNF, INF-γ and 
IL-2 in comparison with infected controls [33].
Taken together, the results obtained in this study 
with the rodent malaria model and those discussed 
on immunomodulatory effects of neem preparations 
evidence the potential of Azadirachta indica for the 
management of complex parasitic diseases in which the 
parasite-host balance is determined by the host’s capac-
ity to mount an adequate immune response, avoiding 
both immune evasion, as a result of an excess of sup-
pression, and immuno-pathological responses, as a 
result of an excess of activation.
The obtained results could suggest to the reader a 
possible direct effect of MMP-9 on parasite survival, 
since this enzyme increases in animals with lower para-
sitaemia, but further studies are needed to prove this. 
Furthermore, in this study Th1 response was not evalu-
ated, but only a pro-inflammatory innate one.
Aiming at the design of a neem phytomedicine able 
to prevent clinical episodes of malaria, in vitro charac-
terization of neem fractions and isolated constituents 
on haemozoin-fed human THP-1 monocytic leukaemia 
cells [30] may allow to identify candidate fractions and 
molecules able to stimulate innate immunity, known 
to be essential in the clearance of Plasmodium blood 
stages. As emerged from this study, in  vivo validation 
of candidates must involve different rodent Plasmo-
dium species and genetically diverse mouse strains, 
in order to account for heterogeneity of parasite-host 
interactions.
Conclusions
This study shows that methanol extracts obtained from 
seed kernel of unripe Azadirachta indica fruits decreased 
by about 30% the proportion of erythrocytes infected 
with the malaria parasite in C57BL/6 mice. In this group, 
the level of TNF and MMP-9 was higher compared to 
other treatment groups, indicating a pro-inflammatory 
effect of these plant extracts, which deserves further 
investigation.
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